Skip to main navigation
September 25, 2023 3:59 PM EDT
Investor Relations
Overview
News & Events
Press Releases
Events & Presentations
Financials & Filings
SEC Filings
Stock
Stock Quote & Chart
Governance
Documents & Charters
Management Team
Board of Directors
Committee Composition
IR Resources
FAQs
Email Alerts
Contact
Contact
DIANTHUS THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE PHASE 1 DATA AND DEBUTS TRADING ON NASDAQ AS DNTH
Press Release
Name
Email
Subject
Comments
Leave this field blank
Search Investors
Search this site
Submit
